Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 251-270 , June 2010

Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis

References 

  1. Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology. 1952 May;21(1):54–63
  2. Le BL, Bignon JD, Raguenes O, Mercier B, Georgelin T, Schnee M, et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. Hum Mol Genet. 1996 Apr;5(4):549–554
  3. Pandya A, Blanton SH, Landa B, Javaheri R, Melvin E, Nance WE, et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cM region on 7q. Genomics. 1996 Dec 1;38(2):227–230
  4. Whitcomb DC, Preston RA, Aston CE, Sossenheimer MJ, Barua PS, Zhang Y, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology. 1996 Jun;110(6):1975–1980
  5. Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science. 1996 Jun 21;272(5269):1755–1762
  6. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996 Oct;14(2):141–145
  7. Gorry MC, Gabbaizedeh D, Furey W, Gates LK, Preston RA, Aston CE, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology. 1997 Oct;113(4):1063–1068
  8. Teich N, Mossner J, Keim V. Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mutat. 1998;12(1):39–43
  9. Ferec C, Raguenes O, Salomon R, Roche C, Bernard JP, Guillot M, et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet. 1999 Mar;36(3):228–232
  10. Chen JM, Mercier B, Audrezet MP, Ferec C. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet. 2000 Jan;37(1):67–69
  11. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000 Jun;25(2):213–216
  12. Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology. 2000 Sep;119(3):615–623
  13. Witt H, Luck W, Becker M, Bohmig M, Kage A, Truninger K, et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA. 2001 Jun 6;285(21):2716–2717
  14. Chandak GR, Idris MM, Reddy DN, Bhaskar S, Sriram PV, Singh L. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet. 2002 May;39(5):347–351
  15. Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, et al. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology. 2002 Oct;123(4):1020–1025
  16. Szmola R, Sahin-Toth M, Chymotrypsin C. (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11227–11232
  17. Masson E, Chen JM, Scotet V, Le MC, Ferec C. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 2008 Feb;123(1):83–91
  18. Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvari B, Landt O, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008 Jan;40(1):78–82
  19. Chen JM, Audrezet MP, Mercier B, Quere I, Ferec C. Exclusion of anionic trypsinogen and mesotrypsinogen involvement in hereditary pancreatitis without cationic trypsinogen gene mutations. Scand J Gastroenterol. 1999 Aug;34(8):831–832
  20. Idris MM, Bhaskar S, Reddy DN, Mani KR, Rao GV, Singh L, et al. Mutations in anionic trypsinogen gene are not associated with tropical calcific pancreatitis. Gut. 2005 May;54(5):728–729
  21. Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006 Jun;38(6):668–673
  22. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):653–658
  23. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):645–652
  24. Rebours V, Boutron-Ruault MC, Schnee M, Ferec C, Le MC, Hentic O, et al. The natural history of hereditary pancreatitis: a national series. Gut. 2009 Jan;58(1):97–103
  25. Chen JM, Raguenes O, Ferec C, Deprez PH, Verellen-Dumoulin C. A CGC>CAT gene conversion-like event resulting in the R122H mutation in the cationic trypsinogen gene and its implication in the genotyping of pancreatitis. J Med Genet. 2000 Nov;37(11):E36
  26. Howes N, Greenhalf W, Rutherford S, O'Donnell M, Mountford R, Ellis I, et al. A new polymorphism for the RI22H mutation in hereditary pancreatitis. Gut. 2001 Feb;48(2):247–250
  27. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004 Mar;2(3):252–261
  28. Le MC, Chen JM, Quere I, Raguenes O, Ferec C, Auroux J. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography. BMC Genet. 2001;2:19
  29. Pfutzer R, Myers E, pplebaum-Shapiro S, Finch R, Ellis I, Neoptolemos J, et al. Novel cationic trypsinogen (PRSS1) N29 T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut. 2002 Feb;50(2):271–272
  30. Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 –> Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem. 2002 Feb 15;277(7):5404–5410
  31. Grocock CJ, Rebours V, Delhaye M, ndren-Sandberg A, Weiss FU, Mountford R, et al. The variable phenotype of the p.A16 V mutation of cationic trypsinogen (PRSS1) in pancreatitis families. Gut. 2009 Dec 1;
  32. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology. 1999 Jul;117(1):7–10
  33. Teich N, Ockenga J, Hoffmeister A, Manns M, Mossner J, Keim V. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology. 2000 Aug;119(2):461–465
  34. Teich N, Le MC, Kukor Z, Caca K, Witzigmann H, Chen JM, et al. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79 K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat. 2004 Jan;23(1):22–31
  35. Le MC, Masson E, Chen JM, Morel F, Ruszniewski P, Levy P, et al. Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet. 2006 Dec;38(12):1372–1374
  36. Masson E, Le MC, Delcenserie R, Chen JM, Ferec C. Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. Hum Genet. 2008 Jun;123(5):521–529
  37. Liu QC, Gao F, Ou QS, Zhuang ZH, Lin SR, Yang B, et al. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis. Chin Med J (Engl). 2008 Jan 20;121(2):108–111
  38. Felderbauer P, Schnekenburger J, Lebert R, Bulut K, Parry M, Meister T, et al. A novel A121 T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site. J Med Genet. 2008 Aug;45(8):507–512
  39. Chen JM, Le MC, Lucas D, Raguenes O, Ferec C. “Loss of function” mutations in the cationic trypsinogen gene (PRSS1) may act as a protective factor against pancreatitis. Mol Genet Metab. 2003 May;79(1):67–70
  40. Kukor Z, Toth M, Sahin-Toth M. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. Eur J Biochem. 2003 May;270(9):2047–2058
  41. Santhosh S, Witt H, te Morsche RH, Nemoda Z, Molnar T, Pap A, et al. A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection against chronic pancreatitis. Pancreas. 2008 Apr;36(3):317–320
  42. Chandak GR, Idris MM, Reddy DN, Mani KR, Bhaskar S, Rao GV, et al. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut. 2004 May;53(5):723–728
  43. Le MC, Chen JM, Le GC, Plessis G, Chipponi J, Chuzhanova NA, et al. Two novel severe mutations in the pancreatic secretory trypsin inhibitor gene (SPINK1) cause familial and/or hereditary pancreatitis. Hum Mutat. 2004 Feb;23(2):205
  44. Threadgold J, Greenhalf W, Ellis I, Howes N, Lerch MM, Simon P, et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut. 2002 May;50(5):675–681
  45. Drenth JP, te MR, Jansen JB. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut. 2002 May;50(5):687–692
  46. Ravnik-Glavac M, Glavac D, di Sant' AP, Chernick M, Dean M. Cystic fibrosis gene mutations detected in hereditary pancreatitis. Pflugers Arch. 1996;431(Suppl. 2):R191–R192
  47. Schneider A, Togel S, Barmada MM, Whitcomb DC. Genetic analysis of the glutathione s-transferase genes MGST1, GSTM3, GSTT1, and GSTM1 in patients with hereditary pancreatitis. J Gastroenterol. 2004 Aug;39(8):783–787
  48. Keller J, Layer P. Idiopathic chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2008;22(1):105–113
  49. Aoun E, Chang CC, Greer JB, Papachristou GI, Barmada MM, Whitcomb DC. Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS One. 2008;3(4):e2003
  50. Boulling A, Le MC, Trouve P, Raguenes O, Chen JM, Ferec C. Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet. 2007 Sep;15(9):936–942
  51. Rinderknecht H, Adham NF, Renner IG, Carmack C. A possible zymogen self-destruct mechanism preventing pancreatic autodigestion. Int J Pancreatol. 1988 Jan;3(1):33–44
  52. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073
  53. Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology. 2001 Dec;121(6):1310–1319
  54. Audrezet MP, Chen JM, Le MC, Ruszniewski P, Robaszkiewicz M, Raguenes O, et al. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet. 2002 Feb;10(2):100–106
  55. Creighton J, Lyall R, Wilson DI, Curtis A, Charnley R. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet. 1999 Jul 3;354(9172):42–43
  56. Chen JM, Piepoli BA, Le BL, Ruszniewski P, Robaszkiewicz M, Deprez PH, et al. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet. 2001 Mar;59(3):189–193
  57. Rossi L, Whitcomb DC, Ehrlich GD, Gorry MC, Parvin S, Sattar S, et al. Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh. Pancreas. 1998 Oct;17(3):278–280
  58. Rossi L, Pfutzer RH, Parvin S, Ali L, Sattar S, Kahn AK, et al. SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. Pancreatology. 2001;1(3):242–245
  59. Schneider A, Suman A, Rossi L, Barmada MM, Beglinger C, Parvin S, et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology. 2002 Oct;123(4):1026–1030
  60. Derikx MH, Szmola R, te Morsche RH, Sunderasan S, Chacko A, Drenth JP. Tropical calcific pancreatitis and its association with CTRC and SPINK1 (p.N34S) variants. Eur J Gastroenterol Hepatol. 2009 Aug;21(8):889–894
  61. Bhatia E, Durie P, Zielenski J, Lam D, Sikora SS, Choudhuri G, et al. Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis. Am J Gastroenterol. 2000 Dec;95(12):3658–3659
  62. Ammann RW. The natural history of alcoholic chronic pancreatitis. Intern Med. 2001 May;40(5):368–375
  63. Perri F, Piepoli A, Stanziale P, Merla A, Zelante L, Andriulli A. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet. 2003 Sep;11(9):687–692
  64. Monaghan KG, Jackson CE, KuKuruga DL, Feldman GL. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet. 2000 Sep 11;94(2):120–124
  65. Truninger K, Kock J, Wirth HP, Muellhaupt B, Arnold C, von WF, et al. Trypsinogen gene mutations in patients with chronic or recurrent acute pancreatitis. Pancreas. 2001 Jan;22(1):18–23
  66. Schneider A, Pfutzer RH, Barmada MM, Slivka A, Martin J, Whitcomb DC. Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States. Dig Dis Sci. 2003 Jun;48(6):1110–1115
  67. Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut. 2001 Jan;48(1):70–74
  68. Norton ID, Apte MV, Dixson H, Trent RJ, Haber PS, Pirola RC, et al. Cystic fibrosis genotypes and alcoholic pancreatitis. J Gastroenterol Hepatol. 1998 May;13(5):496–499
  69. Haber PS, Norris MD, Apte MV, Rodgers SC, Norton ID, Pirola RC, et al. Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystic fibrosis gene. Alcohol Clin Exp Res. 1999 Mar;23(3):509–512
  70. Truninger K, Malik N, Ammann RW, Muellhaupt B, Seifert B, Muller HJ, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. Am J Gastroenterol. 2001 Sep;96(9):2657–2661
  71. Burim RV, Canalle R, Martinelli AL, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis. 2004 Jul;19(4):291–298
  72. Maruyama K, Harada S, Yokoyama A, Naruse S, Hirota M, Nishimori I, et al. Association analysis among polymorphisms of the various genes and chronic alcoholic pancreatitis. J Gastroenterol Hepatol. 2008 Mar;23(Suppl. 1):S69–S72
  73. Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology. 2003 Jun;124(7):1802–1808
  74. Frenzer A, Butler WJ, Norton ID, Wilson JS, Apte MV, Pirola RC, et al. Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol. 2002 Feb;17(2):177–182
  75. Yang B, O'Reilly DA, Demaine AG, Kingsnorth AN. Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis. Alcohol. 2001 Feb;23(2):91–97
  76. Maruyama K, Harada S, Yokoyama A, Mizukami S, Naruse S, Hirota M, et al. Association analyses of genetic polymorphisms of GSTM1, GSTT1, NQO1, NAT2, LPL, PRSS1, PSTI, and CFTR with chronic alcoholic pancreatitis in Japan. Alcohol Clin Exp Res. 2008 Oct 30;
  77. Kimura S, Okabayashi Y, Inushima K, Kochi T, Yutsudo Y, Kasuga M. Alcohol and aldehyde dehydrogenase polymorphisms in Japanese patients with alcohol-induced chronic pancreatitis. Dig Dis Sci. 2000 Oct;45(10):2013–2017
  78. Verlaan M, te Morsche RH, Roelofs HM, Laheij RJ, Jansen JB, Peters WH, et al. Genetic polymorphisms in alcohol-metabolizing enzymes and chronic pancreatitis. Alcohol Alcohol. 2004 Jan;39(1):20–24
  79. Verlaan M, te Morsche RH, Roelofs HM, Laheij RJ, Jansen JB, Peters WH, et al. Glutathione S-transferase Mu null genotype affords protection against alcohol induced chronic pancreatitis. Am J Med Genet A. 2003 Jul 1;120A(1):34–39
  80. Verlaan M, Drenth JP, Truninger K, Koudova M, Schulz HU, Bargetzi M, et al. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet. 2005 Oct;42(10):e62
  81. Ockenga J, Strunck S, Post C, Schulz HU, Halangk J, Pfutzer RH, et al. The role of epoxide hydrolase Y113H gene variant in pancreatic diseases. Pancreas. 2009 May;38(4):e97–e101
  82. Osterreicher CH, Schultheiss J, Wehler M, Homann N, Hellerbrand C, Kunzli B, et al. Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis. Mutagenesis. 2007 Sep;22(5):305–310
  83. Rahman SH, Nanny C, Ibrahim K, O'Reilly D, Larvin M, Kingsnorth AJ, et al. Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity. Dig Dis Sci. 2005 Jul;50(7):1376–1383
  84. Verlaan M, Harbers EG, Pap A, Jansen JB, Peters WH, Drenth JP. Paraoxonase 1-192Q allele is a risk factor for idiopathic chronic pancreatitis. Mol Diagn. 2005;9(1):9–15
  85. Miyasaka K, Ohta M, Takano S, Hayashi H, Higuchi S, Maruyama K, et al. Carboxylester lipase gene polymorphism as a risk of alcohol-induced pancreatitis. Pancreas. 2005 May;30(4):e87–e91
  86. Wilson JS, Gossat D, Tait A, Rouse S, Juan XJ, Pirola RC. Evidence for an inherited predisposition to alcoholic pancreatitis. A controlled HLA typing study. Dig Dis Sci. 1984 Aug;29(8):727–730
  87. de AR, Fonseca MO, Teixeira GP. HLA and chronic alcoholic pancreatitis. A meta-analysis, Arq Gastroenterol. 1993 Jan;30(1):38–42
  88. Kitahara K, Kawa S, Katsuyama Y, Umemura T, Ozaki Y, Takayama M, et al. Microsatellite scan identifies new candidate genes for susceptibility to alcoholic chronic pancreatitis in Japanese patients. Dis Markers. 2008;25(3):175–180
  89. Felderbauer P, Hoffmann P, Einwachter H, Bulut K, Ansorge N, Schmitz F, et al. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol. 2003 Nov 29;3:34
  90. Felderbauer P, Klein W, Bulut K, Ansorge N, Dekomien G, Werner I, et al. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis?. Scand J Gastroenterol. 2006 Mar;41(3):343–348
  91. Murugaian EE, Premkumar RM, Radhakrishnan L, Vallath B. Novel mutations in the calcium sensing receptor gene in tropical chronic pancreatitis in India. Scand J Gastroenterol. 2008 Jan;43(1):117–121
  92. Casanova ML, Bravo A, Ramirez A, Morreale de EG, Were F, Merlino G, et al. Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest. 1999 Jun;103(11):1587–1595
  93. Cavestro GM, Frulloni L, Nouvenne A, Neri TM, Calore B, Ferri B, et al. Association of keratin 8 gene mutation with chronic pancreatitis. Dig Liver Dis. 2003 Jun;35(6):416–420
  94. Treiber M, Schulz HU, Landt O, Drenth JP, Castellani C, Real FX, et al. Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer. J Mol Med. 2006 Dec;84(12):1015–1022
  95. Novis BH, Young GO, Bank S, Marks IN. Chronic pancreatitis and alpha-1-antitrypsin. Lancet. 1975 Oct 18;2(7938):748–749
  96. Witt H, Kage A, Luck W, Becker M. Alpha1-antitrypsin genotypes in patients with chronic pancreatitis. Scand J Gastroenterol. 2002 Mar;37(3):356–359
  97. Haber P, Wilson J, Apte M, Korsten M, Pirola R. Individual susceptibility to alcoholic pancreatitis: still an enigma. J Lab Clin Med. 1995 Mar;125(3):305–312
  98. Teich N, Walther K, Bodeker H, Mossner J, Keim V. Relevance of variants in serum antiproteinases for the course of chronic pancreatitis. Scand J Gastroenterol. 2002 Mar;37(3):360–365
  99. Mahurkar S, Idris MM, Reddy DN, Bhaskar S, Rao GV, Thomas V, et al. Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut. 2006 Sep;55(9):1270–1275
  100. Weiss FU, Behn CO, Simon P, Ruthenburger M, Halangk W, Lerch MM. Cathepsin B gene polymorphism Val26 is not associated with idiopathic chronic pancreatitis in European patients. Gut. 2007 Sep;56(9):1322–1323
  101. Lowenfels AB, Maisonneuve P, Dimagno EP, Elitsur Y, Gates LK, Perrault J, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst. 1997 Mar 19;89(6):442–446
  102. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, Dimagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA. 2001 Jul 11;286(2):169–170
  103. Chen JM, Ferec C. Genes, cloned cDNAs, and proteins of human trypsinogens and pancreatitis-associated cationic trypsinogen mutations. Pancreas. 2000 Jul;21(1):57–62
  104. Sahin-Toth M, Toth M. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun. 2000 Nov 19;278(2):286–289
  105. Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology. 2006 Dec;131(6):1844–1855
  106. Kereszturi E, Szmola R, Kukor Z, Simon P, Weiss FU, Lerch MM, et al. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism. Hum Mutat. 2009 Apr;30(4):575–582
  107. Whitcomb DC. Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut. 1999 Sep;45(3):317–322
  108. Sahin-Toth M. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem. 2000 Jul 28;275(30):22750–22755
  109. Chen JM, Kukor Z, Le MC, Toth M, Tsakiris L, Raguenes O, et al. Evolution of trypsinogen activation peptides. Mol Biol Evol. 2003 Nov;20(11):1767–1777
  110. Nemoda Z, Sahin-Toth M, Chymotrypsin C. (caldecrin) stimulates autoactivation of human cationic trypsinogen. J Biol Chem. 2006 Apr 28;281(17):11879–11886
  111. Kiraly O, Wartmann T, Sahin-Toth M. Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut. 2007 Oct;56(10):1433–1438
  112. Cano DA, Sekine S, Hebrok M. Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology. 2006 Dec;131(6):1856–1869
  113. Oruc N, Lamb J, Kutlu OC, Barmada MM, Money ME, Slivka A, et al. The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis. JOP. 2004 Nov;5(6):457–463
  114. Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis. BMC Gastroenterol. 2006;6:42
  115. Howell WM, Pead PJ, Shek FW, Rose-Zerilli MJ, Armstrong T, Johnson CD, et al. Influence of cytokine and ICAM-1 gene polymorphisms on susceptibility to chronic pancreatitis. J Clin Pathol. 2005 Jun;58(6):595–599
  116. Bohm K, Teich N, Hoffmeister A, Mossner J, Keim V, Bodeker H. Transforming growth factor-beta-1 variants are not associated with chronic nonalcoholic pancreatitis. Pancreatology. 2005;5(1):75–80
  117. Beranek H, Teich N, Witt H, Schulz HU, Mossner J, Keim V. Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1223–1227
  118. Lee SH, Ryu JK, Jeong JB, Lee KY, Woo SM, Park JK, et al. Polymorphisms of the MCP-1 and HSP70-2 genes in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci. 2008 Jun;53(6):1721–1727
  119. Hucl T, Kylanpaa-Back ML, Witt H, Kunzli B, Lempinen M, Schneider A, et al. HFE genotypes in patients with chronic pancreatitis and pancreatic adenocarcinoma. Genet Med. 2007 Jul;9(7):479–483
  120. Masson E, Le MC, Chen JM, Ferec C. Absence of mesotrypsinogen gene (PRSS3) copy number variations in patients with chronic pancreatitis. Pancreas. 2008 Aug;37(2):227–228
  121. Nemoda Z, Teich N, Hugenberg C, Sahin-Toth M. Genetic and biochemical characterization of the E32del polymorphism in human mesotrypsinogen. Pancreatology. 2005;5(2–3):273–278
  122. Keim V, Hoffmeister A, Teich N, Halm U, Scheurlen M, Tannapfel A, et al. The pancreatitis-associated protein in hereditary and chronic alcoholic pancreatitis. Pancreas. 1999 Oct;19(3):248–254
  123. Mahurkar S, Bhaskar S, Reddy DN, Rao GV, Chandak GR. Comprehensive screening for reg1alpha gene rules out association with tropical calcific pancreatitis. World J Gastroenterol. 2007 Nov 28;13(44):5938–5943
  124. Hawrami K, Mohan V, Bone A, Hitman GA. Analysis of islet regenerating (reg) gene polymorphisms in fibrocalculous pancreatic diabetes. Pancreas. 1997 Mar;14(2):122–125

PII: S1521-6918(10)00015-6

doi: 10.1016/j.bpg.2010.02.001

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 251-270 , June 2010

Article Tools

* Image Usage & Resolution